Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve-Reference-Cited by-同舟云学术

Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve

Published:2013-09-08 Issue:11 Volume:44 Page:1056-1061
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Ishikawa Toru¹,Kubota Tomoyuki¹,Horigome Ryoko¹,Kimura Naruhiro¹,Honda Hiroki¹,Iwanaga Akito¹,Seki Keiichi¹,Honma Terasu¹,Yoshida Toshiaki¹

Affiliation:

1. Department of Gastroenterology and Hepatology Saiseikai Niigata Daini Hospital Niigata Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.12222

Reference12 articles.

1. Global cancer statistics

2. Oral branched‐chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma;Ishikawa T;Hepatogastroenterology,2009

3. Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma

4. Portal Hypertension: The Treatment by Splenectomy and Splenorenal Anastomosis with Preservation of the Kidney

5. Partial splenic embolization in the treatment of hypersplenism

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partial Splenic Artery Embolization for the Management of Symptomatic Hypersplenism in Portal Hypertension: Clinical Insights from a Case Series;Journal of Clinical and Experimental Hepatology;2024-09

2. Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia;Journal of Hepatocellular Carcinoma;2024-06

3. Impact of Transarterial Chemoembolization or Hepatic Artery Infusion Chemotherapy on Liver Function after Hepatocellular Carcinoma Resection: An Observational Study;Digestion;2023

4. Simultaneous CSM‐TACE with CalliSpheres® and partial splenic embolization using 8spheres® for hepatocellular carcinoma with hypersplenism: Early prospective multicenter clinical outcome;Frontiers in Oncology;2022-12-01

5. Analysis of predictors after partial splenic embolization for thrombocytopenia with liver cirrhosis;Medicine;2022-10-07